Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends
New

DNAY
Codex DNA Inc
stock NASDAQ

At Close
6/24/2022 3:59:52 PM EDT
2.17USD+8.500%(+0.17)1,707,921
1.70Bid   2.60Ask   0.90Spread IEX
Pre-market
6/24/2022 9:09:16 AM EDT
2.03USD+1.500%(+0.03)87
After-hours
1969-12-31
0.00USD0.000%(0.00)0
OverviewOption ChainHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsMore
open chart   
open chart   
Market Cap
63.795M
Industry
Medical Devices
Next Earnings
2022-08-09 (44d)
Jan 18, 2022
08:09AM EST  Codex DNA Showcases Potential Of Groundbreaking SOLA Enzymatic DNA Synthesis Approach To Accelerate Development Of Vaccines And Therapeutics   Benzinga
08:03AM EST  -- Proprietary short oligo ligation assembly (SOLA) technology used to enzymatically synthesize DNA fragments for the construction of full-length H1 and N1 genes from influenza A virus -- Initial performance results show potentially significant quality, time, and cost advantages compared to traditional chemical synthesis and alternative enzymatic DNA synthesis approaches   GlobeNewswire Inc
Jan 10, 2022
06:53AM EST  Codex DNA Signs Early Access Collaboration And Licensing Agreement With Pfizer To Further Develop Codex DNA's Novel Enzymatic DNA Synthesis Technology For Pfizer's Use In Its Research And Development Of mRNA-based Vaccines And Biotherapies   Benzinga
06:50AM EST  -- Pfizer and Codex DNA agree to strategic, multiyear, early access research collaboration, leveraging Codex DNAs novel enzymatic DNA synthesis (EDS) technology -- Pfizers successful development and commercialization of licensed products could result in milestone payments in excess of $100 million   GlobeNewswire Inc
Dec 30, 2021
12:14PM EST  Shares of synthetic biology company Codex DNA Inc. (DNAY) are rising 12 percent on Thursday's trading after the company announced that it has entered into a research collaboration and license agreement with pharmaceutical company Pfizer Inc.(PFE).   RTTNews
More News
Stats
Avg. Vol. 10 Day
2,458,628
Avg. Vol. 30 Day
853,419
Employees
212
Market Cap
63,794,665
Shares Out.
29,398,463
On/Off Exchange
56%/44%
6 Month Beta
1.74
1 Year Beta
1.71
2 Year Beta
1.72
52 Week Low
1.87
52 Week High
25.70
SMA50
3.56
SMA200
6.45
1 Week
-8.82%
1 Month
-47.96%
3 Month
-53.03%
6 Month
-66.62%
1 Year
-87.78%
2 Year
-88.27%

DNAY Stock Summary

Codex DNA Inc (NASDAQ:DNAY) stock price today is $2.17, and today's volume is 1,707,921. DNAY is up 8.500% today. The 30 day average volume is 853,419. DNAY market cap is 63.795M with 29,398,463 shares outstanding.



Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter @chartexchange_
© 2020 - 2022 ChartExchange LLC